Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score

Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score

Abstract Background Microwave ablation (MWA) is a potentially curative treatment for unresectable patients with hepatocellular carcinoma (HCC) ≤ 3 cm, while its therapeutic efficacy decreases significantly for HCC > 3cm. Previous studies have demonstrated that conventional transarterial chemoembo...

Full description

Bibliographic Details
Main Authors: Zi-yi Zhu, Mu Yuan, Pei-Pei Yang, Bo Xie, Jian-zhu Wei, Zhong-qiang Qin, Zhen Qian, Zhao-Ying Wang, Long-Fei Fan, Jing-yu Qian, Yu-lin Tan
Format: Article
Language:English
Published: BMC 2022-06-01
Series:World Journal of Surgical Oncology
Subjects:
Microwave ablation
Conventional transarterial chemoembolization
Combined treatment
Hepatocellular carcinoma
Time to progression
Survival
Online Access:https://doi.org/10.1186/s12957-022-02643-w

Internet

https://doi.org/10.1186/s12957-022-02643-w

Similar Items